The consideration paid and the relative fair values of the assets acquired and liabilities assumed were as follows: | | | | Consideration transferred: | | | | Common stock | | $ | 3,550,000 | Series C Preferred | | | 93,232,000 | Assumed options | | | 7,085,000 | Company transaction costs settled in equity | | | 4,984,000 | Company transaction costs paid in cash | | | 3,692,000 | Total consideration transferred | | $ | 112,543,000 | | | | | Assets acquired: | | | | Cash and cash equivalents | | $ | 44,000 | Total assets acquired | | $ | 44,000 | | | | | Liabilities assumed: | | | | Accrued expenses and other current liabilities | | $ | 4,965,000 | Total liabilities assumed | | | 4,965,000 | Net assets acquired | | | (4,921,000) | In-process research and development | | | 117,464,000 | Net assets acquired | | $ | 112,543,000 |
|